Skip to content
healthcare.dev

Lansoprazole

NDC 51079-121, lansoprazole, capsule, delayed release pellets, from Mylan Institutional Inc..

Product NDC
51079-121
Status
Listed
Labeler
Mylan Institutional Inc.
Dosage form
CAPSULE, DELAYED RELEASE PELLETS
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090763
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51079-121 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LANSOPRAZOLE30 mg/1

Pharmacologic classes

Inhibition Gastric Acid Secretion [PE]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]

Package NDCNDC-11Package
51079-121-085107901210880 BLISTER PACK in 1 CARTON (51079-121-08) / 1 CAPSULE, DELAYED RELEASE PELLETS in 1 BLISTER PACK (51079-121-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/eea82d0b-6600-4693-a2b8-596a55458f61
  • NADAC price for package 51079012108

    GET /v1/drugs/nadac/51079012108

Use it

Look up 51079-121 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51079-121 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51079-121. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.